My NCBISign In
Logo of advvirolJournal's HomeManuscript SubmissionAims and ScopeAuthor GuidelinesEditorial BoardHome

Volume 2012;  2012

Research Articles

Growth Abnormalities in Children with Chronic Hepatitis B or C
P. Gerner, Andre Hörning, S. Kathemann, K. Willuweit, S. Wirth
Adv Virol. 2012; 2012: 670316. Published online 2012 March 4. doi: 10.1155/2012/670316
PMCID:
PMC3310227
Abstract Full Text PDF–1.2M
The Symptom and Genetic Diversity of Cassava Brown Streak Viruses Infecting Cassava in East Africa
I. U. Mohammed, M. M. Abarshi, B. Muli, R. J. Hillocks, M. N. Maruthi
Adv Virol. 2012; 2012: 795697. Published online 2012 February 21. doi: 10.1155/2012/795697
PMCID:
PMC3290829
Abstract Full Text PDF–2.1M
Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies
David Almond, Chavdar Krachmarov, James Swetnam, Susan Zolla-Pazner, Timothy Cardozo
Adv Virol. 2012; 2012: 803535. Published online 2012 April 2. doi: 10.1155/2012/803535
PMCID:
PMC3323838
Abstract Full Text PDF–1.0M

Review Articles

Oncolytic Virotherapy for Hematological Malignancies
Swarna Bais, Eric Bartee, Masmudur M. Rahman, Grant McFadden, Christopher R. Cogle
Adv Virol. 2012; 2012: 186512. Published online 2011 October 29. doi: 10.1155/2012/186512
PMCID:
PMC3265224
Abstract Full Text PDF–947K
Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies
Sajal K. Ghosh, Susan P. Perrine, Douglas V. Faller
Adv Virol. 2012; 2012: 509296. Published online 2012 March 5. doi: 10.1155/2012/509296
PMCID:
PMC3303631
Abstract Full Text PDF–1.1M
Molecular Understanding of HIV-1 Latency
W. Abbas, G. Herbein
Adv Virol. 2012; 2012: 574967. Published online 2012 April 4. doi: 10.1155/2012/574967
PMCID:
PMC3324883
Abstract Full Text PDF–1.0M
Oncolytic Viruses: The Power of Directed Evolution
Maxine Bauzon, Terry W. Hermiston
Adv Virol. 2012; 2012: 586389. Published online 2011 July 24. doi: 10.1155/2012/586389
PMCID:
PMC3265225
Abstract Full Text PDF–894K
Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
Gamze Isitman, Ivan Stratov, Stephen J. Kent
Adv Virol. 2012; 2012: 637208. Published online 2012 April 29. doi: 10.1155/2012/637208
PMCID:
PMC3350948
Abstract Full Text PDF–1.1M
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells
Christopher A. Alvarez-Breckenridge, Jianhua Yu, Balveen Kaur, Michael A. Caligiuri, E. Antonio Chiocca
Adv Virol. 2012; 2012: 702839. Published online 2011 December 11. doi: 10.1155/2012/702839
PMCID:
PMC3263705
Abstract Full Text PDF–774K
Retargeting of Viruses to Generate Oncolytic Agents
M. H. Verheije, P. J. M. Rottier
Adv Virol. 2012; 2012: 798526. Published online 2011 November 14. doi: 10.1155/2012/798526
PMCID:
PMC3265223
Abstract Full Text PDF–1.1M
Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs
Lisa N. McKernan, David Momjian, Joseph Kulkosky
Adv Virol. 2012; 2012: 805347. Published online 2012 March 5. doi: 10.1155/2012/805347
PMCID:
PMC3303757
Abstract Full Text PDF–1.9M
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson, Nicholas R. Lemoine, Yaohe Wang
Adv Virol. 2012; 2012: 805629. Published online 2012 January 31. doi: 10.1155/2012/805629
PMCID:
PMC3287020
Abstract Full Text PDF–957K
Articles from Advances in Virology are provided here courtesy of Hindawi Publishing Corporation
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk